Loading...
•
Mar 31, 2022
Amphastar Q1 2022 Earnings Report
Reported net revenues of $120.4 million and GAAP net income of $24.3 million for the quarter ended March 31, 2022.
Key Takeaways
Amphastar Pharmaceuticals reported a strong first quarter with net revenues of $120.4 million and a GAAP net income of $24.3 million, driven by strong sales of recently launched products.
Net revenues reached $120.4 million.
GAAP net income was $24.3 million, or $0.47 per share.
Adjusted non-GAAP net income amounted to $24.6 million, or $0.47 per share.
Growth trend is expected to continue in 2022.
Revenue by Segment
Forward Guidance
Amphastar is optimistic that its growth trend will continue in 2022.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...